NIH Guide: Weekly Index for August 26, 2022

Funding Opportunities

• NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
  (PAR-22-224)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is September 25, 2020.
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
  (PAR-22-226)
  National Institute on Aging
  Application Receipt Date(s): October 4, 2021.
• NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
  (PAR-22-227)
  National Institute on Aging
  Application Receipt Date(s): September 29, 2021.
• The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
  (PAR-22-234)
  National Cancer Institute
  Application Receipt Date(s): October 24, 2024
• Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
  (PAR-22-235)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 10, 2022
• Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)
  (PAR-23-024)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): May 1, 2025
• CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
  (PAR-23-027)
  National Institute of Neurological Disorders and Stroke
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)
  (RFA-AI-22-055)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 13, 2023
• REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
  (RFA-AT-23-007)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 10, 2022
• Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
  (RFA-CA-22-028)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
  (RFA-CA-22-029)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-030)
  National Cancer Institute
  Application Receipt Date(s): October 28, 2022
• Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional)
  (RFA-DK-22-013)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 27, 2022
• Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-506)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): October 26, 2022
• Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network Scientific and Data Research Center (APOLLO SDRC) (Collaborative U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-507)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Not Applicable
• Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (DILIN) (U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-508)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Not Applicable
• HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
  (RFA-EB-22-002)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): June 17, 2025
• Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
  (RFA-HD-23-024)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 29, 2023
• Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
  (RFA-HD-23-025)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 29, 2023
• AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32)
  (RFA-HS-22-010)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): December 1, 2022
• Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
  (RFA-NS-23-017)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 30, 2022
• Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
  (RFA-OH-23-001)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): December 6, 2022 On-time submission requires that electronic applications be error-free and made available to CDC for processing from the NIH eRA system on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov no later than 5:00 PM U.S. Eastern Time on the listed application due date.